Neuroblastoma, Drugs

Neuroblastoma Drugs Market to Reach $1.3 Billion, Globally, by 2032 at 6.2% CAGR: Allied Market Research

07.08.2025 - 18:03:19 | prnewswire.co.uk

Allied Market Research United Kingdom United States of America


Web: https://www.alliedmarketresearch.com  
Follow Us on: LinkedIn Twitter

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/neuroblastoma-drugs-market-to-reach-1-3-billion-globally-by-2032-at-6-2-cagr-allied-market-research-302070970.html

en | CA7609751028 | NEUROBLASTOMA | boerse | 67998697 |